Per Malmström
101 – 120 of 157
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
The cost-effectiveness of post-operative radiotherapy after breast conservation surgery in stage I-II breast cancer in Sweden
(
- Contribution to journal › Published meeting abstract
- 2003
-
Mark
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.
(
- Contribution to journal › Article
-
Mark
Psychological profile in patients with Stages I and II breast cancer: associations of psychological profile with tumor biological prognosticators.
(
- Contribution to journal › Article
-
Mark
Prolonged tamoxifen therapy; effects on contralateral breast cancer, endometrial cancer incidence and cardiovascular mortality
(
- Contribution to journal › Published meeting abstract
- 2002
-
Mark
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
(
- Contribution to journal › Article
-
Mark
Physical performance, toxicity, and quality of life as assessed by the physician and the patient
(
- Contribution to journal › Article
-
Mark
Validering av ny prognostisk modell i lymfkörtelnegativ bröstcancer baserad på automatiskt utvärderade DNA flödescytometriska data
2002) Svenska Läkaresällskapets Riksstämma(
- Contribution to conference › Poster
- 2001
-
Mark
S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase) : association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients
(
- Contribution to journal › Article
-
Mark
Timing of quality of life (QoL) assessments as a source of error in oncological trials
(
- Contribution to journal › Article
-
Mark
Image cytometric Auer class-I identifies a real low risk group among lymph node negative premenopausal breast cancer patients
(
- Contribution to journal › Published meeting abstract
-
Mark
Histological grade, its three components and flow cytometric S-phase as prognostic markers in premenopausal women with node negative breast cancer
(
- Contribution to journal › Published meeting abstract
- 2000
-
Mark
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels
(
- Contribution to journal › Article
-
Mark
Quantitative 201Tl SPET imaging in the follow-up of treatment for brain tumour: a sensitive tool for the early identification of response to chemotherapy?
(
- Contribution to journal › Article
-
Mark
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer : a randomised trial
(
- Contribution to journal › Article
-
Mark
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group
(
- Contribution to journal › Article